Evidence map›Paper›PMID 38328539›Full record

ArticleFrontiers in public health2023

Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among adult population: qualitative analysis across six different states of India.

Sheela Godbole, Vishal Diwan, Saibal Das, Mahendra M Reddy, Madhanraj Kalyanasundaram, Dilipkumar Rajendran, Dipankar Biswas, Megha Mamulwar, Rajnarayan R Tiwari, Joydeep Majumder and 22 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 7 institutions in 1 country.

Sheela Godbole *ICMR-National AIDS Research Institute, Pune, India.
Vishal Diwan *ICMR-National Institute for Research in Environmental Health, Bhopal, India.
Saibal Das *ICMR-Centre for Ageing and Mental Health, Kolkata, India.
Mahendra M Reddy *ICMR-Regional Medical Research Centre Gorakhpur, Gorakhpur, India.
Madhanraj Kalyanasundaram *ICMR-National Institute of Epidemiology, Chennai, India.
Dilipkumar Rajendran *ICMR-National Institute of Epidemiology, Chennai, India.
Dipankar Biswas *ICMR-Regional Medical Research Centre, NE Region, Dibrugarh, India.
Megha Mamulwar *ICMR-National AIDS Research Institute, Pune, India.
Rajnarayan R Tiwari *ICMR-National Institute for Research in Environmental Health, Bhopal, India.
Joydeep Majumder *ICMR-Centre for Ageing and Mental Health, Kolkata, India.
Ayush Mishra *ICMR-Regional Medical Research Centre Gorakhpur, Gorakhpur, India.
Santhosh Kumar Muthusamy *ICMR-National Institute of Epidemiology, Chennai, India.
M Memeenao *ICMR-Regional Medical Research Centre, NE Region, Dibrugarh, India.
Nivedita Gupta *Division of Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Swati Gupta *Division of Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Leyanna Susan George *Division of Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Prajakta Kadale *ICMR-National AIDS Research Institute, Pune, India.
Tanwi Trushna *ICMR-National Institute for Research in Environmental Health, Bhopal, India.
Indranil Saha *ICMR-Centre for Ageing and Mental Health, Kolkata, India.
Umaer Alam *ICMR-Regional Medical Research Centre Gorakhpur, Gorakhpur, India.
Jeyashree Kathiresan *ICMR-National Institute of Epidemiology, Chennai, India.
Sanjib Kumar Phukan *ICMR-Regional Medical Research Centre, NE Region, Dibrugarh, India.
Suvarna Sane *ICMR-National AIDS Research Institute, Pune, India.
Kalyan Bhowmik *ICMR-Centre for Ageing and Mental Health, Kolkata, India.
Girijesh Kumar Yadav *ICMR-Regional Medical Research Centre Gorakhpur, Gorakhpur, India.
Vinaykumar Krishnamurthy *Directorate of Public Health and Preventive Medicine, Government of Tamil Nadu, Chennai, India.
Punananda Gogoi *ICMR-Regional Medical Research Centre, NE Region, Dibrugarh, India.
Kedar Padhye *ICMR-National AIDS Research Institute, Pune, India.
Rajni Kant *ICMR-Regional Medical Research Centre Gorakhpur, Gorakhpur, India.
Pramit Ghosh *ICMR-Regional Medical Research Centre, NE Region, Dibrugarh, India.
Mahesh Kharat *ICMR-National AIDS Research Institute, Pune, India.
Aditi Kulkarni *ICMR-National AIDS Research Institute, Pune, India.
National AIDS Research Institute · INRegional Medical Research Centre · INRegional Medical Research Centre · INNational Institute of Epidemiology · INICMR National Institute for Research in Environmental HealthIndian Council of Medical Research · INGovernment of Tamil Nadu · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: India launched the COVID-19 vaccination drive on 16th January 2021 by vaccinating the adult population above 18 years of age. This was followed by the introduction of an additional precaution dose. As on 18th October 2022, 1,02,66,96,808 (1.02 Billion) first dose and 94, 95, 39,516 (949 Million) second doses of COVID-19 vaccine were administered. However, when compared to the uptake of the primary doses, the precaution dose uptake lagged behind with only 21,75, 12,721 (217 million) doses administered. Even though, the uptake of the primary doses remained optimal, irrespective of different interventions by the Government of India, the uptake of the precaution dose remained poor. In this context, the Ministry of Health & Family Welfare wanted to understand the facilitators and Barriers for precaution dose uptake among adults so that future immunization campaigns could address these issues. Methods: An exploratory qualitative study was conducted to assess the facilitators and barriers for COVID-19 precaution dose uptake at community level across 6 different states in India. From each of the states, two districts with the highest and lowest rates of COVID-19 vaccine precaution dose uptake were selected. In each of these districts, 2 block Primary Healthcare Centres (PHCs), one with high and one with low uptake were identified. Within these block PHCs, a PHC field area with high and low precaution dose uptakes was identified. From the identified sites a minimum of four IDIs, four FGDs were conducted among the community members. KIIs of the State Immunization Officers, District Immunisation Officers, PHC Medical Officers, healthcare workers like Accredited Social Health Activist/Auxiliary Nurse Midwife were also conducted. The data was audio recorded and it was transcribed, translated and analysed using framework approach. Results: It was observed that rise in COVID-19 cases prompted the community to take the precaution dose, this along with the cost of hospitalization and the number of productive days being lost as a result of being infected resulted in vaccine uptake. The fear of non-availability of COVID-19 vaccines latter on also prompted people for vaccine uptake. While the barriers were, poor accessibility to vaccination centers, long hours of travel, poor road connectivity and lack of transportation facilities. However, the most prominent barriers observed across all study sites was that a sense of pandemic fatigue and complacency had developed both among the providers as well as the beneficiaries. Other barriers include differences in vaccination schedules and longer duration between the primary doses of some vaccines. Media was identified to be both a barrier and facilitator for Covid-19 Precaution dose uptake. Even though media played an important role in disseminating information in the beginning of the campaign, it was soon followed by the circulation of both misinformation and disinformation. Discussion: The study identified that dissemination of accurate information and community involvement at each stage of planning and implementation are crucial for the success of any campaign. Efforts should be constantly made to address and re-invent strategies that will be most suitable for the needs of the community. Therefore, in order to ensure successful vaccination campaigns, it is crucial that along with political will it is also important to have a decentralized approach with inter-sectoral coordination with different stakeholders such as healthcare workers, community members and the different departments such as the local self-governments, education department, law & order department etc. These lessons learnt from COVID-19 vaccination campaigns must not be forgotten and must be applied in future vaccination campaigns and while framing public health policies.

Indexed as

COVID-19COVID-19 VaccinesAdultHumansImmunizationIndiaVaccinationCOVID-19 VaccinesbarriersCOVID-19facilitatorsprecaution dosevaccine hesitancy

Identifiers

PMID38328539
PMCPMC10847555
OpenAlexW4391172860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.